Modelling the effects of chloroquine on KCNJ2-linked short QT syndrome

Oncotarget
Cunjin LuoHenggui Zhang

Abstract

A gain-of-function KCNJ2 D172N mutation in KCNJ2-encoded Kir2.1 channels underlies one form of short QT syndrome (SQT3), which is associated with increased susceptibility to arrhythmias and sudden death. Anti-malarial drug chloroquine was reported as an effective inhibitor of Kir2.1 channels. Using biophysically-detailed human ventricle computer models, this study assessed the effects of chloroquine on SQT3. The ten Tusscher et al. model of human ventricular cell action potential was modified to recapitulate functional changes in the inward rectifier K+ current (IK1) due to heterozygous and homozygous forms of the D172N mutation. Mutant formulations were incorporated into multi-scale models. The blocking effects of chloroquine on ionic currents were modelled using IC50 and Hill coefficient values from literatures. Effects of chloroquine on action potential duration (APD), effective refractory period (ERP) and pseudo-ECGs were quantified. It was shown that chloroquine caused a dose-dependent reduction in IK1, prolonged APD, and decreased the maximum voltage heterogeneity. Chloroquine prolonged QT interval and declined the T-wave amplitude. Although chloroquine reduced tissue's temporal vulnerability, it increased the minimum sub...Continue Reading

References

Jan 1, 1991·Molecular Genetic Medicine·R M Cook-Deegan
Apr 11, 2000·Journal of Molecular and Cellular Cardiology·P TaggartP Kallis
Jun 6, 2000·Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society·M J Ackerman, R A Banvard
Feb 15, 2001·Cardiology·I GussakP Bjerregaard
May 4, 2002·Circulation Research·Kazutaka Gima, Yoram Rudy
Aug 7, 2002·The Journal of Clinical Investigation·Martin Tristani-FirouziRabi Tawil
Mar 4, 2003·Nature Reviews. Molecular Cell Biology·Peter J Hunter, Thomas K Borg
Jul 24, 2003·Journal of Cardiovascular Electrophysiology·Mark WarrenJosé Jalife
Aug 20, 2003·Circulation·Fiorenzo GaitaMartin Borggrefe
Dec 6, 2003·American Journal of Physiology. Heart and Circulatory Physiology·K H W J ten TusscherA V Panfilov
Dec 17, 2003·Circulation·Ramon BrugadaCharles Antzelevitch
Apr 20, 2004·Journal of the American College of Cardiology·Fiorenzo GaitaChristian Wolpert
May 26, 2004·Circulation·Chloé BellocqArthur A M Wilde
Mar 12, 2005·Circulation Research·Silvia G PrioriJosé Jalife
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Rainer SchimpfChristian Wolpert
Aug 17, 2005·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Daniel L WeissOlaf Dössel
Oct 18, 2005·Journal of Electrocardiology·Martin BorggrefeRainer Schimpf
Mar 28, 2006·American Journal of Physiology. Heart and Circulatory Physiology·K H W J ten Tusscher, A V Panfilov
Aug 24, 2006·European Heart Journal·Carla GiustettoFiorenzo Gaita
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Daniel G Hackam, Donald A Redelmeier
Dec 19, 2006·BMJ : British Medical Journal·Pablo PerelKhalid S Khan
Oct 5, 2007·Progress in Biophysics and Molecular Biology·Alan P BensonArun V Holden
Jan 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Aldo A Rodríguez-MenchacaJosé A Sánchez-Chapula
Apr 18, 2008·Progress in Biophysics and Molecular Biology·R C P KerckhoffsF W Prinzen
Dec 9, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T BrennanB Rodriguez
Mar 17, 2009·Journal of Molecular and Cellular Cardiology·Aziza El HarchiJules C Hancox
Aug 28, 2009·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Angelica Lopez-IzquierdoJose A Sanchez-Chapula
Oct 16, 2009·Cardiology in Review·Umang Patel, Behzad B Pavri
Oct 20, 2009·Journal of Molecular and Cellular Cardiology·Eleonora GrandiDonald M Bers
Nov 11, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·José Jalife
Mar 23, 2010·Progress in Biophysics and Molecular Biology·Martin FinkNicolas P Smith
Dec 14, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Thomas O'Hara, Yoram Rudy
Feb 7, 2012·Cardiovascular Research·Ismail AdeniranHenggui Zhang
Nov 1, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Mathias WilhelmsGunnar Seemann
Nov 2, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Axel LoeweGunnar Seemann
Nov 2, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Mark PotseAngelo Auricchio
Nov 5, 2014·British Journal of Pharmacology·Yongfeng YuanHenggui Zhang

❮ Previous
Next ❯

Citations

Apr 27, 2018·Expert Opinion on Therapeutic Targets·Jules C HancoxHenggui Zhang
Jun 18, 2020·APL Bioengineering·Minki HwangEun Bo Shim

❮ Previous
Next ❯

Software Mentioned

MIDDLE
ENDO

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.